Press Releases Baxter International Inc. Borsa Italiana

Equities

4BAX

US0718131099

Real-time Estimate Tradegate Other stock markets 09:48:49 2024-07-17 am EDT			5-day change	1st Jan Change
32.57 ^EUR	+2.64%		+1.72%	-9.34%

Jul. 16	North American Morning Briefing : Retail Sales, -2-	DJ
Jul. 15	Medical Technology Companies Poised for Another 'Solid' Quarter, Morgan Stanley Says	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Baxter International : Issues Urgent Medical Device Recall for Volara System Single-Patient Use Circuit	Jul. 16	PU
Baxter Declares Quarterly Dividend	Jul. 16	BU
Baxter International : Issues Urgent Medical Device Recall for Life2000 Ventilator Due to Potential Battery Charger Dongle Damage	Jul. 10	PU
Baxter International : 2023 SASB Index	Jul. 10	PU
Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact	Jul. 10	BU
Baxter International : 2023 Corporate Responsibility Report2022 Corporate Responsibility Report2022 Task Force for Climate-related Financial Disclosures (TCFD) Index2021 Corporate Responsibility Report	Jul. 09	PU
Fitch Affirms and Withdraws Baxter's Ratings	Jun. 11	AQ
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference	Jun. 06	BU
New Cohort Study Data Shows Baxter's Expanded Hemodialysis, Known as HDx Therapy is associated with approximately 25% Lower Mortality Rate for up to Four Years	May. 30	AQ
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years	May. 29	BU
Baxter to Present at Jefferies 2024 Global Healthcare Conference	May. 23	BU
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive	May. 15	BU
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication	May. 13	BU
Baxter to Present at Bank of America 2024 Health Care Conference	May. 07	BU
Baxter Declares Quarterly Dividend	May. 07	BU
Baxter International : Q1 2024 Financial Schedules	May. 02	PU
Baxter: Q1 Earnings Snapshot	May. 02	AQ
Baxter Reports First-Quarter 2024 Results	May. 02	BU
Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO	Apr. 24	AQ
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.	Apr. 11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Baxter International Inc. Borsa Italiana

Equities

4BAX

US0718131099

Press Releases

Filters